Aarca Research Company
IHRA (Intelligent Health Risk Assessment) is a first-of-its-kind prognostic screening solution for Type 2 Diabetes and Hypertension, using non-invasive technology. Our deep-tech product identifies if you are showing early indications of these conditions. This point of care product is a portable primary care solution that can also be used in large-scale preventive healthcare screenings. Contact us today to learn more! #ForAHealthierTomorrow #GoLongOnHealth
Industry:
P4 Medicine
Headquarters:
Orange, Connecticut, United States
Zip:
11-50
Founded Date:
2019-02-08
Employees Number:
11-50
Last Funding Date:
Pre-Seed
Last Funding Type:
contact@aarcaresearch.com
Register and Claim Ownership